| Literature DB >> 25338824 |
Rachel E D Climie, Velandai Srikanth, Richard Beare, Laura J Keith, James Fell, Justin E Davies, James E Sharman.
Abstract
BACKGROUND: Central hemodynamics help to maintain appropriate cerebral and other end-organ perfusion, and may be altered with ageing and type 2 diabetes mellitus (T2DM). We aimed to determine the associations between central hemodynamics and brain structure at rest and during exercise in people with and without T2DM.Entities:
Mesh:
Year: 2014 PMID: 25338824 PMCID: PMC4221700 DOI: 10.1186/s12933-014-0143-6
Source DB: PubMed Journal: Cardiovasc Diabetol ISSN: 1475-2840 Impact factor: 9.951
Figure 1Example aortic pressure waveform separated into reservoir pressure and excess pressure. Total measured pressure is equal to the sum of reservoir pressure and excess pressure. Aortic reservoir pressure represents the cyclic increase in aortic volume (aortic distension that occurs during systole) and decrease in volume (aortic recoil that occurs during diastole). Excess pressure is representative of the excess work required by the left ventricle for ejection of stroke volume and is analogous to left ventricular flow.
Study participant characteristics
|
|
|
|
|
|---|---|---|---|
| Male, n (%) | 17 (47) | 19 (51) | 0.56 |
| Age (years) | 63 ± 9 | 52 ± 8 | <0.001 |
| Body mass index (kg/m2) | 30.5 ± 4.8 | 25.9 ± 3.3 | <0.001 |
| Waist:hip (ratio) | 0.91 ± 0.06 | 0.84 ± 0.1 | 0.002 |
| Current smoker, n (%) | 3 (8) | 3 (8) | 0.97 |
| Hypercholesterolemia, n (%) | 25 (66) | 10 (27) | 0.001 |
| Normotensive, n (%) | 15 (39) | 28 (76) | 0.002 |
| 24ABPM systolic BP (mmHg) | 134 ± 13 | 130 ± 11 | 0.21 |
| 24ABPM diastolic BP (mmHg) | 75 ± 8 | 79 ± 6 | 0.016 |
| Daytime systolic BP (mmHg) | 138 ± 14 | 136 ± 13 | 0.50 |
| Nighttime systolic BP (mmHg) | 119 ± 12 | 113 ± 11 | 0.016 |
| Duration of diabetes (years) | 6 ± 6 | - | - |
| Antihypertensive medications, n (%) | 24 (63) | 0 (0) | <0.001 |
| Oral hypoglycemic medications, n (%) | 26 (68) | 0 (0) | <0.001 |
| Urinary albumin (mg/L) | 9.00 ± 11.19 | 7.85 ± 7.59 | 0.60 |
| Insulin, n (%) | 5 (13) | 0 (0) | 0.016 |
| Statin, n (%) | 25 (66) | 0 (0) | <0.001 |
| Glucose (mmol/L) | 7.5 ± 1.8 | 4.7 ± 0.4 | <0.001 |
| Glycated hemoglobin (HbA1C) (%) | 7.2 ± 0.8 | 5.5 ± 0.3 | <0.001 |
| Insulin (IU/mL) | 10.2 ± 8.6 | 2.4 ± 4.7 | <0.001 |
| Total cholesterol (mmol/L) | 4.4 ± 1.0 | 5.4 ± 1.0 | <0.001 |
| HDL cholesterol (mmol/L) | 1.3 ± 0.4 | 1.6 ± 0.4 | 0.002 |
| Triglycerides (mmol/L) | 1.4 ± 0.6 | 1.0 ± 0.5 | 0.003 |
Data expressed as mean ± standard deviation or %. T2DM, type 2 diabetes mellitus; 24ABPM, 24 hour ambulatory blood pressure monitoring; BP, blood pressure; HDL, high density lipoprotein. P is for between group analyses.
Brain magnetic resonance imaging (MRI) volumes in patients with type 2 diabetes mellitus (T2DM) and healthy participants
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
| ||
| Gray matter volume (ml) | 567.36 ± 77.81 | 607.81 ± 63.01 | 0.014 (−17.23, 21.21) | 0.84 |
| White matter volume (ml) | 583.92 ± 76.03 | 604.84 ± 80.53 | −0.005 (−15.98, 14.48) | 0.92 |
| Left hippocampal volume (ml) | 2.43 ± 0.37 | 2.55 ± 0.38 | −0.019 (−0.17, 0.14) | 0.86 |
| Right hippocampal volume (ml) | 2.51 ± 0.36 | 2.56 ± 0.39 | 0.046 (−0.14, 0.21) | 0.70 |
| White matter lesion volume (ml) | 3.34 ± 2.38 | 3.44 ± 2.39 | −0.148 (−1.93, 0.54) | 0.26 |
Unadjusted MRI volumes are presented in the first two columns; β refers to standardized beta coefficient for the association between T2DM and MRI variables determined by ANCOVA and adjusted for age, sex and total intracranial volume. P value is for relation of diabetes status with MRI variables.
Differences in central and peripheral hemodynamic variables between patients with type 2 diabetes mellitus (T2DM) and healthy participants at rest, during exercise and the change from rest to exercise
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
| Peak reservoir pressure (mm Hg) | 36 ± 8 | 32 ± 4 | 0.016 | 18 ± 10 | 15 ± 5 | 0.17 | −19 ± 10 | −17 ± 10 | 0.49 |
| Reservoir pressure integral (Pa.s) | 1872 ± 520 | 1869 ± 369 | 0.97 | 794 ± 485 | 694 ± 263 | 0.40 | −1413 ± 570 | −1441 ± 454 | 0.81 |
| Peak excess pressure (mm Hg) | 35 ± 9 | 30 ± 4 | 0.005 | 73 ± 16 | 58 ± 12 | <0.001 | 37 ± 19 | 27 ± 11 | 0.013 |
| Excess pressure integral (Pa.s) | 630 ± 197 | 493 ± 98 | <0.001 | 1644 ± 437 | 1255 ± 472 | <0.001 | 970 ± 468 | 776 ± 470 | 0.079 |
| Central systolic BP (mm Hg) | 114 ± 11 | 103 ± 10 | <0.001 | 132 ± 14 | 114 ± 13 | <0.001 | 18 ± 12 | 11 ± 11 | 0.015 |
| Central pulse pressure (mm Hg) | 45 ± 9 | 37 ± 5 | <0.001 | 52 ± 12 | 39 ± 7 | <0.001 | 8 ± 9 | 2 ± 7 | 0.003 |
| 0.Pulse pressure amplification (ratio) | 1.2 ± 0.1 | 1.3 ± 0.1 | <0.001 | 1.5 ± 0.1 | 1.6 ± 0.1 | 0.007 | 0.26 ± 0.11 | 0.23 ± 0.09 | 0.37 |
| Augmented pressure (mm Hg) | 13 ± 4.8 | 8 ± 5 | <0.001 | 9 ± 6 | 4 ± 4 | <0.001 | −4 ± 5 | −4 ± 3 | 0.78 |
| Augmentation index (%) | 29 ± 6.8 | 21 ± 10 | <0.001 | 17 ± 9 | 10 ± 6 | 0.001 | −12 ± 7 | −11 ± 6 | 0.68 |
| Augmentation index (at 75 bpm) | 23 ± 6 | 13 ± 11 | <0.001 | 25 ± 9 | 14 ± 11 | <0.001 | 0.8 ± 9 | 1 ± 7 | 0.73 |
| *Adjusted augmentation index (%) | 26 ± 6.7 | 23 ± 6.7 | <0.001 | 14.6 ± 8.0 | 11.9 ± 7.9 | <0.001 | −11.6 ± 6.7 | −11.5 ± 6.8 | 0.58 |
| Aortic pulse wave velocity (m/s) | 8.01 ± 2.16 | 6.29 ± 1.42 | <0.001 | 9.73 ± 2.10 | 7.02 ± 1.43 | <0.001 | 2.14 ± 2.59 | 0.32 ± 2.71 | 0.004 |
| Heart rate (bpm) | 64 ± 8 | 58 ± 8 | 0.001 | 92 ± 12 | 86 ± 12 | 0.043 | 27 ± 9 | 28 ± 9 | 0.58 |
| Cardiac output (L/min) | 5.24 ± 0.90 | 4.50 ± 0.73 | <0.001 | 8.22 ± 1.54 | 7.91 ± 1.28 | 0.35 | 2.9 ± 1.3 | 3.4 ± 1.3 | 0.103 |
| Stroke volume (mL) | 82 ± 11 | 78 ± 15 | 0.26 | 90 ± 13 | 93 ± 14 | 0.36 | 7 ± 12 | 14 ± 11 | 0.017 |
|
| |||||||||
| Brachial systolic BP (mm Hg) | 124 ± 12 | 114 ± 9 | <0.001 | 155 ± 17 | 134 ± 14 | <0.001 | 31 ± 13 | 20 ± 13 | <0.001 |
| Brachial diastolic BP (mm Hg) | 68 ± 8 | 65 ± 6 | 0.064 | 77 ± 9 | 73 ± 9 | 0.097 | 8 ± 6 | 9 ± 8 | 0.93 |
| Brachial pulse pressure (mm Hg) | 55 ± 10 | 49 ± 5 | 0.002 | 78 ± 15 | 60 ± 10 | <0.001 | 23 ± 11 | 11 ± 10 | <0.001 |
| Systemic vascular resistance (d.s.cm−5) | 1369 ± 243 | 1503 ± 268 | 0.027 | 1004.38 ± 201 | 973 ± 157 | 0.45 | −354 ± 206 | −529 ± 247 | 0.001 |
Data expressed as mean ± standard deviation. BP, blood pressure. P is for between group analyses. *Augmentation index adjusted for age, sex, heart rate and height.
Multivariable analysis of resting hemodynamics and gray matter volume in patients with type 2 diabetes mellitus (T2DM) and healthy participants
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| |||||
| Gray matter/total intracranial volume | Aortic pulse wave velocity | −0.007 (−0.014, −0.050−2) | −0.47 | 0.036 | 0.16 |
| Age | −0.001 (−0.002, 0.001) | −0.15 | 0.44 | ||
| Sex | 0.006 (−0.019, −0.030) | 0.088 | 0.64 | ||
| 24ABPM daytime systolic BP | 2.94−5 (−0.001, 0.001) | 0.013 | 0.94 | ||
| Heart rate | 0.001 (−0.001, 0.001) | 0.18 | 0.28 | ||
|
| |||||
| Gray matter/total intracranial volume | Excess pressure integral | 0.60−4 (−0.119−3, −0.200−5) | −0.23 | 0.043 | 0.68 |
| Age | −0.020 (−0.002, −0.001) | −0.49 | <0.001 | ||
| Sex | −0.028 (−0.039, −0.018) | −0.55 | <0.001 | ||
| 24ABPM daytime systolic BP | 4.30−5 (−0.390−3, 0.477−3) | 0.021 | 0.84 | ||
| Heart rate | 0.32−4 (−0.001, 0.001) | −0.010 | 0.93 | ||
| White matter lesion/total intracranial volume | Augmentation index | 5.91−5 (0.9−5, 0.12−3) | 0.52 | 0.021 | 0.16 |
| Age | 2.01−5 (0.29−4, 0.7−4) | 0.14 | 0.41 | ||
| Sex | 0.28−3 (−0.001, 0.001) | 0.12 | 0.57 | ||
| 24ABPM daytime systolic BP | −0.10−4 (−0.39−4, 0.22−4) | −0.093 | 0.58 | ||
| Heart rate | 9.17−6 (−0.41−4, 0.59−4) | 0.060 | 0.71 | ||
| Central pulse pressure | 0.11−3 (0.28−3, 0.19−3) | 0.48 | 0.010 | 0.19 | |
| Age | 2.79−5 (−0.18−4, 0.74−4) | 0.19 | 0.23 | ||
| Sex | 0.12−3 (−0.001, 0.001) | −0.045 | 0.79 | ||
| 24ABPM daytime systolic BP | 0.17−4 (−0.49−4, 0.14−4) | −0.093 | 0.58 | ||
| Heart rate | 1.40−5 (−0.35−4, 0.63−4) | 0.091 | 0.57 |
R2 refers ANOVA adjusted R square and P value is for the independent variable. 24ABPM, 24 hour ambulatory blood pressure monitoring; BP, blood pressure. All models adjusted for age, sex, ambulatory daytime systolic BP and heart rate.
Figure 2Univariate association (unadjusted) between excess pressure integral and gray matter volume in patients with type 2 diabetes mellitus (T2DM) and healthy participants at rest.